e-Drug3D

1903

M CANNABIDIOL


INN
CANNABIDIOL

(is an active metabolite)

cas 50725-17-2
CLASS

NERVOUS SYSTEM
TREATMENT OF SEIZURES ASSOCIATED WITH LENNOX-GASTAUT SYNDROME OR DRAVET SYNDROME
ANTICONVULSANT
AGONIST OF CANNABINOID (CB) RECEPTORS

ROUTE (list)

-

ATC code

N03AX24

PK parameters

Target

TARGET CANNABINOID RECEPTOR

DrugCentral

Transient receptor potential cation channel subfamily V member 1 UNIPROT Q8NER1 TRPV1

G-protein coupled receptor 55 UNIPROT Q9Y2T6 GPR55

Download SDF file 1,3-Benzenediol, 2-[(1R,6R)-3-(hydroxymethyl)-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-

Formula:
C21H30O3

Calculated chemical properties:

MW 330.45
NB_atoms 24
XLogP 4.82
PSA 57.292
NB_HD 3
NB_HA 3
fsp3 0.52
Lipinski(0=no;1=yes) 1

FDA
-

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL